• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG FLUENCY PLUS ENDOVASCULAR STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG FLUENCY PLUS ENDOVASCULAR STENT GRAFT Back to Search Results
Catalog Number FEM12040
Device Problems Positioning Failure (1158); Material Deformation (2976)
Patient Problems No Consequences Or Impact To Patient (2199); No Known Impact Or Consequence To Patient (2692)
Event Date 07/02/2015
Event Type  malfunction  
Event Description
It was reported that during placement of the stent graft in a right upper arm fistula, the shaft of the delivery system got stretched and appeared to be broken.Therefore, the stent graft could not be deployed.The delivery system was retracted without issue.Another stent graft was used to complete the procedure successfully.There was no reported patient injury.
 
Manufacturer Narrative
The device history records are being reviewed.The event is currently under investigation.
 
Manufacturer Narrative
The lot records have been reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.The review shows that no remarkable incidents occurred during the manufacturing process.No relevant manufacturing process changes were implemented, that could have led to the event reported.Based on the sample condition it could be confirmed that the stent graft could not completely deployed.The stent graft was found partially released.Furthermore, the outer sheath was found elongated, which indicates that increased friction affected the delivery system during attempt of stent graft deployment.Additionally, the stent graft could not be completely deployed during evaluation.No indication was found for manufacturing related issue.Potential factors which may have contributed to the reported issue have been considered.Therefore previous investigations of similar complaints have been reviewed.This type of event may be associated with a difficult patient anatomy, which led to increased friction and the subsequent partial stent graft deployment.In this case the anatomy of the tracking vessel was tortuous.Insufficient flushing of the device could be another contributing factor.Based on the information available and the evaluation of the sample returned, a definite root cause for the reported failure could not be determined.In reviewing the labeling supplied with this product it was found that the instructions for use (ifu) sufficiently address the potential risks.Regarding preparation of the device the ifu states that "prior to loading the endovascular system over a guide wire, both ports must be flushed with sterile saline (.).Flushing these lumens will also facilitate stent graft deployment." in this case flushing was performed.Regarding the anatomy of the placement site the ifu states: "the safety and effectiveness of the device when placed across a tight bend (.) has not been evaluated.Prior to stent graft deployment, ensure that the proximal (inflow) stent graft end is positioned in a straight section of the lumen to reduce the risk of higher deployment forces and possible endovascular system failure" and "do not kink the delivery catheter or use excessive force during delivery to the target lesion.".Furthermore, the ifu states: "if unusual resistance or high deployment force is encountered during stent graft deployment, abort the procedure, remove the delivery system and use an alternative device." the information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLUENCY PLUS ENDOVASCULAR STENT GRAFT
Type of Device
ENDOVASCULAR STENT GRAFT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstrasse 6
karlsruhe 76227
GM  76227
Manufacturer (Section G)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG -9681442
wachhausstrasse 6
karlsruhe 76227
GM   76227
Manufacturer Contact
daniela mueller
wachhausstrasse 6
karlsruhe 76227
GM   76227
0497219445
MDR Report Key4949506
MDR Text Key17934143
Report Number9681442-2015-00104
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P130029/S003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative,company representative
Reporter Occupation Other
Type of Report Initial
Report Date 07/02/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/18/2017
Device Catalogue NumberFEM12040
Device Lot NumberANYG2472
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer07/23/2015
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 07/02/2015
Initial Date FDA Received07/29/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/25/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age66 YR
Patient Weight78
-
-